HQY HEALTHEQUITY, INC.
Price Chart
Executive Summary
Three HQY insiders (EVP General Counsel, EVP Chief Commercial Officer, and a Director) sold a total of ~$1.19M in open-market sales within 7 days of the company's strong Q1 FY27 earnings release (May 28, 2026). The earnings beat on revenue and EPS, raised guidance, and a $1B buyback authorization are clearly positive, but the insider selling cluster — particularly the EVP General Counsel's $675K sale — introduces a cautionary signal that partially offsets the bullish earnings read.
Key Financial Metrics
Actionable Insight
The strong earnings beat and raised guidance are the dominant signal, but the cluster of insider sales (especially the EVP General Counsel's $675K sale) on the same day as the earnings release warrants monitoring. The sales are small relative to market cap but involve senior executives. Watch for any follow-on insider sales in the next 30 days; if they continue, it would reduce confidence in the earnings narrative. The $1B buyback authorization provides a floor.
Key Facts
- Three insiders sold a total of ~$1.19M in open-market sales (May 28-29, 2026)
- EVP General Counsel Ladd Delano sold 7,500 shares for $675K on May 28
- EVP Chief Commercial Officer Fiore sold 3,142 shares for $298K on May 29
- Director Wellborn sold 2,439 shares for $220K on May 28 (also exercised options)
- Q1 FY27 revenue $354.6M (+7% YoY), net income $69.4M (+29% YoY), EPS $0.82 (+34% YoY)
- Adjusted EBITDA margin expanded to 46% from 42% YoY
- FY27 guidance raised: revenue $1.41-1.42B, Adj. EBITDA $625-633M
- Board authorized additional $1.0B share repurchase program
- Company repurchased 1.5M shares for $123M in Q1
Financial Impact
Insider sales total ~$1.19M, representing ~0.016% of $7.6B market cap — trivial in size but notable for timing and seniority
Risk Factors
- Insider sales may indicate executives see limited near-term upside despite strong results
- Revenue growth of 7% is modest; acceleration needed to sustain premium valuation
- FY27 guidance implies ~7% revenue growth at midpoint — deceleration from prior year's pace
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-HQY-1780434245557 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 2, 2026
12d ago
|
Insider Cluster
| $85.21 $86.03 | ▲ +0.96% | ▲ +0.56% | $88.34 (+3.67%) |
|
May 28, 2026
17d ago
|
8-K
| $87.99 $90.64 | ▲ +3.01% | ▲ +2.75% | $88.34 (+0.40%) |
|
May 28, 2026
17d ago
|
Press Release
| $87.99 $90.64 | ▲ +3.01% | ▲ +2.74% | $88.34 (+0.40%) |
|
May 8, 2026
5w ago
|
8-K
| $81.65 $81.65 | · 0.00% | ▲ +0.14% | $88.34 (+8.19%) |
|
Mar 17, 2026
12w ago
|
Press Release
| $79.57 $81.13 | ▲ +1.96% | ▲ +2.23% | $88.34 (+11.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access